Free Trial

GT Biopharma (GTBP) SEC Filings & 10K Form

GT Biopharma logo
$2.94
-0.07 (-2.33%)
(As of 10/31/2024 ET)

Recent GT Biopharma SEC Filings

DateFilerForm TypeView
10/21/2024
8:13 PM
GT Biopharma (Issuer)
URBAN ALAN LOUIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
10:15 AM
CYTOVANCE BIOLOGICS INC (Filed by)
GT Biopharma (Subject)
Form SCHEDULE 13G/A
07/02/2024
3:50 PM
GT Biopharma (Filer)
Form 424B3
06/30/2024
11:15 PM
GT Biopharma (Filer)
Form EFFECT
06/27/2024
10:17 AM
GT Biopharma (Filer)
Form S-1/A
06/27/2024
8:34 AM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:17 PM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
8:36 PM
GT Biopharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/17/2024
3:26 PM
GT Biopharma (Filer)
Form DEFA14A
06/07/2024
4:25 PM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
7:31 PM
BRISTOL INVESTMENT FUND LTD (Filed by)
GT Biopharma (Subject)
Form SC 13G/A
05/23/2024
5:04 AM
GT Biopharma (Filer)
Form 424B5
05/23/2024
5:02 AM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:00 PM
GT Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
2:26 PM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
4:00 PM
GT Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
1:46 PM
ARMISTICE CAPITAL, LLC (Filed by)
GT Biopharma (Subject)
Form SC 13G/A
02/01/2024
11:15 AM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
2:30 PM
GT Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
4:21 PM
GT Biopharma (Filer)
Form DEF 14A
11/06/2023
4:23 PM
GT Biopharma (Filer)
Form DEFA14A
11/06/2023
4:25 PM
GT Biopharma (Filer)
Form DEFA14A
11/01/2023
8:00 AM
GT Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GTBP) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners